Diagrow Exim Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 27491.18%
- Profit Growth 4180.59%
- Ebitda 856.16%
- Net Worth 22.30%
- Total Assets 1559.84%
About Diagrow Exim
Diagrow Exim Private Limited (DEPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 March 2014 and has a history of Ten years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nilay Jogani and Kunal Shah serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U36932MH2014PTC254818
- Company No.
254818
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Diagrow Exim?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilay Jogani  | Director | 13-May-2016 | Current |
| Kunal Shah | Director | 30-Mar-2021 | Current |
Financial Performance of Diagrow Exim.
Diagrow Exim Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27491.18% increase. The company also saw a substantial improvement in profitability, with a 4180.59% increase in profit. The company's net worth Soared by an impressive increase of 22.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diagrow Exim?
In 2018, Diagrow Exim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dimar Construction Private LimitedNilay Jogani is a mutual person
- Diamar Construction Private Limited
Nilay Jogani is a mutual person
- Hem- Chet Homes Llp
Kunal Shah is a mutual person
- World Techno Diamonds Limited Liability Partnership
Kunal Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Diagrow Exim?
Unlock and access historical data on people associated with Diagrow Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diagrow Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diagrow Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
